Soccer fans enter the pitch during a clash between supporters at Kanjuruhan Stadium in Malang, East Java, Indonesia, Saturday, Oct. 1, 2022.
10:12 JST, October 2, 2022
129 dead after fans stampede to exit Indonesian soccer match
MALANG, Indonesia (AP) — Panic at an Indonesian soccer match after police fired tear gas to stop brawls left 129 dead, mostly trampled to death, police said Sunday.
Several fights between supporters of the two rival soccer teams were reported inside the Kanjuruhan Stadium in East Java province’s Malang city after the Indonesian Premier League game ended with Persebaya Surabaya beating Arema Malang 3-2.
The brawls that broke out just after the game ended late night Saturday prompted riot police to fire tear gas, which caused panic among supporters, said East Java Police Chief Nico Afinta.
Hundreds of people ran to an exit gate in an effort to avoid the tear gas. Some suffocated in the chaos and others were trampled, killing 34 almost instantly.
More than 300 were rushed to nearby hospitals to treat injuries but many died on the way and during a treatment, Afinta said.
He said the death toll is likely still increasing, since many of about 180 injured victims’ conditions were deteriorating.
Top Articles in World
-
South Korea Tightens Rules on Foreigners Buying Homes in Seoul Metro Area
-
Nepal Bus Crash Kills 19 People, Injures 25 Including One Japanese National
-
Govt to Utilize ODA for Ensuring Economic Security; Securing Energy, Critical Minerals Sought
-
Ukrainian Ambassador Closely Watching Japan’s Revision of Defense Export Rules, Hopes for Future Arms Support
-
China, India Tapping into Promising African Market; Beijing Announces Tariff Cuts, Both Countries Aim to Expand Exports
JN ACCESS RANKING
-
Producer Behind Pop Group XG Arrested for Cocaine Possession
-
Japan PM Takaichi’s Cabinet Resigns en Masse
-
Man Infected with Measles Reportedly Dined at Restaurant in Tokyo Station
-
Japan Figure Skating Legend Yuzuru Hanyu Is Proud Disaster Survivor and Gold Medalist, Vows to Continue Support Efforts
-
iPS Treatments Pass Key Milestone, but Broader Applications Far from Guaranteed

